Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 11/2012

01-11-2012 | Correspondence

Difficulties Reducing Inappropriate Prescribing of Proton Pump Inhibitors in the Elderly

Authors: Emily Reeve, Michael D. Wiese

Published in: Drugs & Aging | Issue 11/2012

Login to get access

Excerpt

We congratulate Hamzat et al. [1] on their work, which demonstrated the efficacy of an educational strategy to reduce inappropriate proton pump inhibitor (PPI) prescribing in elderly inpatients. The discussion provided a good picture of the issues surrounding PPI use, and we were particularly pleased to see that this study was conducted in the elderly (age >65 years), as this group is renowned as a group that is under studied, despite being the most likely population to suffer ill-effects from PPIs [2, 3], and therefore the most likely to benefit from any such intervention to reduce PPI use. …
Literature
1.
Hamzat H, Sun H, Ford JC, et al. Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy. Drugs Aging. 2012; 29(8):681–90.PubMed
2.
Peterson G. Proton pump inhibitors: not so innocuous in the elderly? Aust Pharm. 2007;26(7):534–6.
3.
Martin RM, Dunn NR, Freemantle S, et al. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol. 2000;50(4):366–72.PubMedCrossRef
4.
Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.PubMedCrossRef
5.
Batuwitage BT, Kingham JG, Morgan NE, et al. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J. 2007;83(975):66–8.PubMedCrossRef
6.
Tam VC, Knowles SR, Cornish PL, et al. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Can Med Assoc J. 2005;173(5):510–5.CrossRef
7.
Reeve E, Shakib S, Hendrix I, et al. Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. doi:10.​1007/​s11096-012-9704-5.
8.
Williams ME, Pulliam CC, Hunter R, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52(1):93–8.PubMedCrossRef
9.
Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648–54.PubMedCrossRef
10.
Beer C, Loh P-k, Peng YG, et al. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2(2):37–43.
Metadata
Title
Difficulties Reducing Inappropriate Prescribing of Proton Pump Inhibitors in the Elderly
Authors
Emily Reeve
Michael D. Wiese
Publication date
01-11-2012
Publisher
Springer International Publishing AG
Published in
Drugs & Aging / Issue 11/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-012-0024-1

Other articles of this Issue 11/2012

Drugs & Aging 11/2012 Go to the issue

Review Article

Optimal Management of Recurrent Prostate Cancer in Older Patients

Original Research Article

Effect of External Variables on the Performance of the Geriatric Comorbidity Score Derived from Prescription Claims in the Community-Dwelling Elderly

Original Research Article

Optimal Remifentanil Dosage for Intubation without Muscle Relaxants in Elderly Patients

Adis Drug Profile

Melatonin Prolonged Release

Original Research Article

Comparison of Intranasal Ketorolac Tromethamine Pharmacokinetics in Younger and Older Adults

Correspondence

Authors’ Reply to Reeve and Wiese: “Difficulties Reducing Inappropriate Prescribing of Proton Pump Inhibitors in the Elderly”
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits